Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Drugs can change hair growth and this is important because it can upset people.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Certain gene changes and hormone levels are linked to female hair loss.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.